Home › Funds › Samsara BioCapital, LLC › PMVP
Samsara BioCapital, LLC position in PMVP
PMV PHARMACEUTICALS INC · Health Care
Samsara BioCapital, LLC reported holding 7,240,000 shares of PMVP (PMV PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$12.1M, representing 1.15% of its reported portfolio and ranking #12 among its reported holdings. Samsara BioCapital, LLC first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Samsara BioCapital, LLC's PMVP position evolved
Samsara BioCapital, LLC first disclosed a stake in PMVP in Q3 2026 at 7,240,000 shares (US$12.1M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 7.24M | $12.09M | New |
About PMVP and 13F data
PMVP (PMV PHARMACEUTICALS INC) is a Health Care company. 24 other funds we track also report a position in PMVP — the largest reported positions include BML Capital Management, LLC (US$12.2M), TANG CAPITAL MANAGEMENT LLC (US$12.2M), Sio Capital Management, LLC (US$6.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PMVP
- BML Capital Management, LLC 7.33M sh · $12.24M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 7.29M sh · $12.17M · Q3 2026
- Sio Capital Management, LLC 3.63M sh · $6.07M · Q3 2026
- Euclidean Capital LLC 2.63M sh · $4.39M · Q3 2026
- Boxer Capital Management, LLC 2.05M sh · $3.42M · Q3 2026
- Aldebaran Capital, LLC 489.54K sh · $817.53K · Q3 2026
More on Samsara BioCapital, LLC
FAQ
How long has Samsara BioCapital, LLC held PMVP?
Samsara BioCapital, LLC has disclosed PMVP holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Samsara BioCapital, LLC's current position in PMVP?
As of Q3 2026, Samsara BioCapital, LLC holds 7.24M shares of PMVP (PMV PHARMACEUTICALS INC), valued at $12.09M, representing 1.15% of its reported portfolio and ranking #12.
Has Samsara BioCapital, LLC been buying or selling PMVP?
In the latest 13F filing (Q3 2026), Samsara BioCapital, LLC newly opened its position in PMVP.
Which other funds hold PMVP?
Other major institutional holders of PMVP include BML Capital Management, LLC, TANG CAPITAL MANAGEMENT LLC, Sio Capital Management, LLC, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.